Trending Now
Companies
M*Modal is 3M’s $1 Billion Commitment to Healthcare’s Cloud Computing Market
Since world-renowned computer scientist John McCarthy first coined the term ‘artificial intelligence’ in 1965, it’s inspired IT experts to push the limits of what’s been deemed possible. Some decades later, Michael Finke got together with a group of Carnegie Mellon IT extra-ordinaires to make a go of speech recognition. From there, M*Modal was born and began providing clinical documentation and transcription services to their healthcare clients...
Funds
Bain Capital Pursues Life Sciences, Leverages Private Capital Pedigree
Bain Capital has been a Wall Street fixture since the early days of the 1980s. The investment firm has flourished since their founding and now operates several specialized business units. Founded in 2016, their life sciences fund focuses on companies that are innovative leaders in the healthcare field...
People
Former Healthcare Banker Ganot Goes All In With Solid BioScience
Ilan Ganot had another life before his two-year-old son was diagnosed with Duchenne muscular dystrophy. He lived in London with his wife and three children and worked at JPMorgan as an investment banker. In 2012, his son was diagnosed with the degenerative muscle disease at aged two and that was the day that changed everything...
Features
Women Leaders Crucial to Long Term Success of Health Tech
Everything from failed period-tracking apps to unconscious biases in artificial intelligence points to the need for more diversity in health technology. Ideas, innovations and inventions are only as good as the people behind them and the assumptions they rely on when creating the next-big-tech-thing...
Popular Articles
Top 50 Healthcare Technology CEOs of 2019
The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2019. An extensive process was run to evaluate the...
Alex Gorsky Is The All-American CEO
Alex Gorsky is having a bad year. As chief executive officer of pharmaceutical giant Johnson & Johnson (J&J), he’s been on the hot seat...
Thermo Fisher Scientific CEO Marc Casper Makes a Strong Impression
There is much ado about Marc Casper. By all accounts, the CEO of Thermo Fisher Scientific is whip-smart and has a keen eye for what’s happening next in the biotech business but may leave something to be desired when it comes to up-keeping employee morale. Overall, however, under his stewardship the company continues to thrive...
JNJ Worldwide Chairman Jennifer Taubert, An Exceptional Leader
Jennifer Taubert needs no introduction in the field of healthcare. Named as one of Fortune Magazine’s Most Powerful Women the last three years running, she was recently promoted to the role of Executive Vice President, Worldwide Chairman of Pharmaceuticals for Johnson & Johnson...
HealthStream CFO Announces Resignation
After more than a decade on the job, HealthSteam CFO Gerard Hayden announced plans to retire early next year.
Hayden has led the company’s finance team since May 2008. He plans to retire in March after filing HealthStream’s 2018 annual report with the Securities and Exchange Commission...
Tabula Rasa Launches Medwise Software 2.0
Tabula Rasa has recently announced their February 2019 rollout of Medwise 2.0, a proprietary software platform that monitors safety, risk and adverse drug issues....
Baxter International Acquires True Process
True Process, a medical software business based in Wisconsin, has found itself a buyer in Fortune 500 medical equipment firm Baxter International. After they...
SoftBank and TenX Healthcare Announce Collaboration to Promote Practical Healthcare Innovations
Innovative healthcare technology company TenX Healthcare has announced a new collaborative partnership with SoftBank Telecom America, the mobile and IT service division of the Japanese...
Hillhouse Capital Management, Quan Capital Spearhead NextCure’s $93 Million Series B
Biopharmaceutical firm NextCure Inc. has revealed that Quan Capital and Hillhouse Capital Management lead the investor roster as the company finishes its series B financial round. Additional series B investors backing the immunotherapy-focused Maryland company include ArrowMark Partners, Ping An Ventures, Surveyor Capital, Taiho Ventures, Bay City Capital and NS Investment...
Healthcare Fraud Scheme Leads to $1.2 billion in Medicare Losses
One of the largest healthcare fraud schemes in history was finally brought down after 24 people – including executives of several telemedicine and DME (durable medical equipment) companies and three licensed medical practitioners – were arrested last week...
